About Vemurafenib
Class: | BRAF inhibitor
Use: | Treatment of unresectable or metastatic melanoma with BRAF V600E mutation
Adult dose: | 960 mg orally twice daily (240 mg tablets, taken as four tablets)
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Rash, arthralgia, fatigue, photosensitivity, nausea, diarrhea, liver enzyme elevations
Contraindications: | Hypersensitivity to vemurafenib or any component of the formulation; concomitant use with strong CYP3A in
Drug Class
BRAF inhibitor
Uses & Indications
Treatment of unresectable or metastatic melanoma with BRAF V600E mutation
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: F. Hoffmann La Roche, ITALY
Package Size
56's (7 Blisters x 8)
Price & Supplier
Price in UAE: AED 13182.70
Dosage Information
Adult Dose
960 mg orally twice daily (240 mg tablets, taken as four tablets)
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Rash, arthralgia, fatigue, photosensitivity, nausea, diarrhea, liver enzyme elevations
Contraindications & Precautions
Hypersensitivity to vemurafenib or any component of the formulation; concomitant use with strong CYP3A inhibitors
Important Warnings
Risk of new malignancies (non-melanoma skin cancers), hepatotoxicity, QT prolongation, and serious skin reactions; monitor liver function tests regularly during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.